No Need to Pause Lorazepam Before Ketamine Infusion
There is no requirement to pause lorazepam for 12–24 hours before receiving a ketamine infusion—in fact, benzodiazepines like lorazepam are commonly co-administered with ketamine to mitigate its adverse effects.
Rationale for Concurrent Use
The FDA-approved ketamine label explicitly states: "Administer a benzodiazepine, if clinically indicated, for the prevention of neuropsychological manifestations during emergence from anesthesia" and recommends to "Augment ketamine hydrochloride injection with an intravenous benzodiazepine for the prevention of neuropsychological manifestations during emergence" 1. This guidance applies to both induction and maintenance phases of ketamine administration.
Multiple guidelines support benzodiazepine co-administration with ketamine:
- The 2026 Indian guideline on depression management discusses ketamine dosing for treatment-resistant depression without any contraindication or warning about concurrent benzodiazepine use 2
- The 2026 headache management guideline recommends: "Consider administering clonidine and/or a low-dose benzodiazepine to partially mitigate psychotomimetic and sympathomimetic adverse effects of ketamine" 3
- The 2012 endoscopy sedation curriculum notes that "The use of midazolam in combination with ketamine is reported to minimize [emergence] reaction" 4
Evidence of Beneficial Interaction
Research demonstrates that lorazepam specifically reduces ketamine's adverse effects:
- A 1998 study found that lorazepam 2 mg PO reduced ketamine-associated emotional distress and showed a trend toward decreasing perceptual alterations, though it did exacerbate sedation and amnesia 5
- Earlier studies from 1978 and 1980 showed that 4 mg lorazepam (oral, IM, or IV) effectively reduces psychic sequelae of ketamine to acceptable limits, with even 2 mg lorazepam being superior to 10 mg diazepam 6, 7
Clinical Context: Alcohol Withdrawal Studies
Interestingly, ketamine has been successfully used as an adjunct to ongoing lorazepam infusions in benzodiazepine-resistant alcohol withdrawal:
- A 2018 study of 30 ICU patients showed that ketamine initiated an average of 41.4 hours after lorazepam infusion initiation achieved symptom control within 1 hour, with significant reductions in lorazepam requirements at 24 hours 8
- A 2015 study of 23 patients found ketamine well-tolerated when added to existing benzodiazepine therapy 9
These studies demonstrate not only safety but potential synergy when ketamine is added to existing benzodiazepine therapy.
Important Caveats
Respiratory Depression Risk
The primary concern with combining these medications is additive respiratory depression and excessive sedation 10, 4. However, this is managed through:
- Appropriate monitoring (continuous vital signs, pulse oximetry, telemetry)
- Having emergency airway equipment immediately available
- Using lower doses when combining agents
- Ensuring administration by personnel experienced with both medications
The FDA label specifically addresses this: ketamine should be administered by physicians experienced in airway management, with continuous vital sign monitoring and emergency equipment immediately available 1.
Timing Considerations for Other Combinations
Note that olanzapine (not lorazepam) requires a 2-hour waiting period before administering parenteral benzodiazepines due to respiratory depression risk 10. This does not apply to lorazepam-ketamine combinations.
Practical Approach
For a 49-year-old woman on chronic lorazepam receiving ketamine infusion for treatment-resistant depression:
- Continue lorazepam at her usual dose (no washout period needed)
- Consider whether additional benzodiazepine may be beneficial to reduce ketamine's emergence phenomena
- Ensure appropriate monitoring per ketamine infusion protocols (telemetry, blood pressure checks every 4 hours minimum, pulse oximetry) 3
- Have emergency airway equipment immediately available
- Monitor for excessive sedation, which may require dose adjustment of either medication
The combination is not only safe but potentially beneficial when properly monitored, with benzodiazepines serving as a protective agent against ketamine's psychotomimetic effects rather than a contraindication.